Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Doughty St
Roper Medical Office Building
Charleston, SC 29403
Education & Training
- Topiwala National Medical CollegeClass of 2005
- Medical University of South CarolinaResidency, Child Neurology
- Medical University of South CarolinaFellowship, Epilepsy
Certifications & Licensure
- CA State Medical License 2024 - 2027
- NY State Medical License 2005 - 2026
- TX State Medical License 2023 - 2026
- UT State Medical License 2023 - 2026
- AZ State Medical License 2023 - 2025
- CO State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
- Join now to see all
Publications & Presentations
PubMed
- The eACT study design and methods: A sequential, multiple assignment, randomized trial of A novel adherence intervention for youth with epilepsy.Janelle L Wagner, Anup D Patel, Heather Huszti, Matthew Schmidt, Gigi Smith
Contemporary Clinical Trials. 2024-12-01 - Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.Juliet K Knowles, Aaron E L Warren, Ismail S Mohamed, Carl E Stafstrom, Hyun Yong Koh
Annals of Clinical and Translational Neurology. 2024-11-01 - A unique case of tactile-induced reflex myoclonic epilepsy of infancy evolving into childhood absence epilepsy.Jeffrey Rodgers, Sonal Bhatia
Epileptic Disorders. 2024-10-22
Press Mentions
- Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingNovember 3rd, 2023
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BApril 30th, 2024
- FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B PatientsApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: